Journal for ImmunoTherapy of Cancer (Nov 2023)
644 A phase 1 dose escalation study of GCC19CART – A novel CoupledCAR® therapy for subjects with metastatic colorectal cancer
- Ning Li,
- Xun Li,
- Tingting Liang,
- Xi Huang,
- Chengfei Pu,
- Ruihong Zhu,
- Zhao Wu,
- Lei Xiao,
- Suxia Luo,
- Chang Wang,
- Jiuwei Cui,
- Zhenzhou Yang,
- Victor Lu,
- Naifei Chen,
- Lingling Zhao,
- Yusheng Huang,
- Jun Bie,
- Haiyang Tang,
- Yizhuo Wang,
- Beibei Jia,
- Dongqi Chen,
- Yongping Song
Affiliations
- Ning Li
- Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- Xun Li
- Navigate BiPharma
- Tingting Liang
- Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
- Xi Huang
- 2Innovative Cellular Therapeutics, Shanghai, China
- Chengfei Pu
- Innovative Cellular Therapeutics, Shanghai, China
- Ruihong Zhu
- Innovative Cellular Therapeutics, Shanghai, China
- Zhao Wu
- Laboratory of Biomedical Ultrasonics/Gynecological Oncology Laboratory and
- Lei Xiao
- 9Innovative Cellular Therapeutics, Inc., Rockville, MD, USA
- Suxia Luo
- Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
- Chang Wang
- 1The First Bethune Hospital of JLU, Changchun, China
- Jiuwei Cui
- Cancer Center, The First Hospital of Jilin University, Changchun, China
- Zhenzhou Yang
- 4The Second Affiliated Hospital of CQMU, Chongqing, China
- Victor Lu
- 9Innovative Cellular Therapeutics, Inc., Rockville, MD, USA
- Naifei Chen
- 1The First Bethune Hospital of JLU, Changchun, China
- Lingling Zhao
- 1The First Bethune Hospital of JLU, Changchun, China
- Yusheng Huang
- 4The Second Affiliated Hospital of CQMU, Chongqing, China
- Jun Bie
- 8Nanchong Central Hospital, Nanchong, China
- Haiyang Tang
- 2Innovative Cellular Therapeutics, Shanghai, China
- Yizhuo Wang
- 1The First Bethune Hospital of JLU, Changchun, China
- Beibei Jia
- 2Innovative Cellular Therapeutics, Shanghai, China
- Dongqi Chen
- 2Innovative Cellular Therapeutics, Shanghai, China
- Yongping Song
- 3Henan Cancer Hospital, Zhengzhou, China
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0644
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.